Archiving Physical vs Electronic Clinical Records: GCP-Compliant Strategies

Archiving clinical records is an essential step in the lifecycle of a clinical trial, ensuring long-term preservation, traceability, and compliance with global Good Clinical Practice (GCP) guidelines. As technology evolves, sponsors face the choice between maintaining physical paper archives or adopting electronic solutions. Understanding the differences, benefits, limitations, and compliance considerations of each approach is vital for informed decision-making. This article compares physical and electronic clinical record archiving under GCP regulations, providing actionable guidance for pharma professionals and clinical trial stakeholders.

Whether you’re managing an eTMF, traditional paper files, or a hybrid model, having a compliant and secure archiving process supports audit readiness and regulatory transparency.

What Are Clinical Records?

Clinical records include any document, form, image, or dataset used to support the conduct, reporting, and verification of a clinical trial. These may encompass:

• Informed Consent Forms (ICFs)
• Case Report Forms (CRFs)
• Investigator Brochures and Protocols
• Source data and lab reports
• Trial Master File (TMF) documentation
• Audit trails and metadata from Electronic Data Capture (EDC) systems

GCP Requirements for Archiving Clinical Records

According to EMA and USFDA guidelines, all essential trial documents must be archived to demonstrate compliance with GCP. The ICH E6(R2) specifies:

• Retention for at least 2 years after the last marketing approval or longer based on regional regulations
• Secure and controlled access
• Readability, retrievability, and audit readiness
• Documented SOPs for archiving procedures

Retention periods vary across regions. For instance, EU law mandates a 25-year minimum retention period for the TMF under EU Regulation 536/2014.

Physical Archiving: Traditional but Reliable

Pros of Physical Archiving:

• Familiar format for regulatory inspectors
• Minimal technological dependency
• Suitable for small-scale or site-based trials

Cons of Physical Archiving:

• High storage space and facility costs
• Risk of physical deterioration (fire, humidity, pests)
• Limited retrievability and searchability
• Transport and access delays for audits

Physical archives must be maintained under GMP documentation standards with environmental controls and access logs.

Electronic Archiving: Efficient and Scalable

Pros of Electronic Archiving:

• Easy access and fast retrieval
• Audit trail and metadata preservation
• Space and cost savings
• Integration with EDC, CTMS, and eTMF systems

Cons of Electronic Archiving:

• Requires validation under 21 CFR Part 11 and EU Annex 11
• Vulnerable to cybersecurity risks if not encrypted
• File format obsolescence risk (non-PDF/A, legacy formats)

To comply with GCP, electronic archives must undergo full computer system validation (CSV) and demonstrate controlled access, integrity, and backup.

Hybrid Model: Best of Both Worlds

Many organizations adopt a hybrid archiving approach:

• Store critical ICFs and CRFs in physical form at site or sponsor level
• Maintain TMF and audit logs in electronic form (eTMF)
• Digitize paper documents for redundancy

This approach supports flexibility, inspector expectations, and disaster recovery preparedness.

Steps for GCP-Compliant Archiving Strategy

1. Define Archiving Policy and SOP

• Identify what documents are archived physically vs electronically
• Set region-specific retention periods
• Specify roles (Archivist, QA, IT, Sponsor)
• Include security, retrieval, and audit procedures

Use reference SOPs from pharma SOP templates to structure internal policies.

2. Implement Secure Storage Systems

• Use access-controlled offsite storage for paper files
• Use encrypted, validated cloud platforms for digital archives
• Maintain backup, disaster recovery, and access logs

3. Ensure Retrieval and Audit Readiness

• Maintain searchable document inventories
• Implement eTMF dashboards with audit logs
• Demonstrate document integrity on retrieval

Timely data access helps meet stability studies correlation and regulatory inquiry timelines.

Case Study: Transitioning to eArchive in a Global Trial

A multinational CRO transitioned from physical to electronic TMF during a Phase III diabetes trial. They validated a Part 11 compliant eArchive, digitized legacy documents, and trained QA staff. Regulatory inspections by Health Canada and EMA showed improved document traceability, reduced query response time, and zero findings related to archiving practices.

Best Practices for Long-Term Archiving

• Use PDF/A and XML formats for future-proof readability
• Maintain parallel logs for both physical and digital archives
• Conduct annual archive audits
• Include archiving strategy in trial planning documents
• Assign clear accountability to sponsors and CROs

Conclusion: Choose the Right Archiving Strategy

Both physical and electronic archiving approaches have their merits and limitations. While physical archives offer a familiar structure, electronic records provide scalability and access efficiency. The right choice depends on trial size, region, technology infrastructure, and budget. Above all, sponsors must ensure that their archiving practices are GCP-compliant, audit-ready, and documented in robust SOPs.

Whether you go physical, electronic, or hybrid, ensure your archiving system supports the long-term integrity and accessibility of your clinical trial data.

Further Reading:

• Drug regulatory compliance
• Real-time stability studies